logo en
  • Home
  • Manufacturing
    • Manufacturing
    • OEM Manufacturing
    • Quality Control
  • About the Factory
    • About the Factory
    • Our History
    • Management
    • Certificates
    • Partners
    • Licenses
    • Achievements
    • Special Evaluation of Labour Conditions
    • Videos
  • News
  • Products
  • Contacts
    • Contacts
    • Quality Claims
  • 简体中文(中国)
  • Russian (Russia)
  • You are here:  
  • Home /
  • News

News

The «Medsintez» plant took part in the international ‘Urals Healthcare 2019’ forum exhibition

Details
Published: 29 April 2019

From April 16 to 19, Urals Healthcare 2019, the specialized International Exhibition and Forum, was held at the Yekaterinburg Expo Centre, where a stand of Medsintez was presented too. The forum exhibition of medical equipment, tools, supplies, pharmaceuticals as well as medical and spa services was held for the first time ever.

Read more ...

Triazavirin is recommended to treat viral infections that exacerbate bronchial asthma

Details
Published: 10 January 2019

On December 21, 2018, Epidemiology And Treatment Of Allergic Diseases, a scientific and practical conference of the Sverdlovsk region's allergologists and immunologists, was held, where Triazavirin, the domestic antiviral drug, was recommended as a treatment for viral infections that exacerbate bronchial asthma.

Read more ...

The «Medsintez» plant carries on implementation of the large-scale ‘Import-substituting production of genetic engineering and analog insulin from own substance’ project

Details
Published: 18 December 2018

Today, the company has a developed technology for obtaining the RosinsulinAspart and RosinsulinGlargin substances as well as their dosage forms.

Read more ...

The «Rosinsulin M» trial results have been presented at a meeting of the Sverdlovsk Association of Endocrinologists

Details
Published: 22 November 2018

On November 15, 2018, within the framework of a regular meeting of the Sverdlovsk Association of Endocrinologists, the results of clinical trials of Rosinsulin M Mix 30/70, 2-phase genetically engineered human insulin, were presented in Rymar Oksana's report “Basic clinical and laboratory parameters in patients with type 2 diabetes mellitus amid the therapy of combined domestic insulins and metformins in the real-world clinical practice."

Read more ...

«Triazavirin» was presented at the ‘Antiviral Azoloazine-Based Drugs for Influenza and SARS: From Theory to Practice’ symposium. Broadcast.

Details
Published: 21 November 2018
The symposium was held as part of the 5th-Anniversary All-Russian Interdisciplinary Scientific and Practical Conference ‘Socially Significant and Particularly Dangerous Infectious Diseases’, which was held in Sochi from October 30 to November 2, 2018.

Read more ...

Page 17 of 23

  • Start
  • Prev
  • 12
  • 13
  • 14
  • 15
  • 16
  • 17
  • 18
  • 19
  • 20
  • 21
  • Next
  • End

Privacy Policy

Copyright © 2003-2026

+7 (34370) 2-50-61

+7 (34370) 2-54-95

Torgovaya 15, Novouralsk, Sverdlovsk region, Russia, 624130

Contacts

Для использования сайта дайте согласие на обработку файлов cookie и ваших персональных данных, в т.ч. с помощью сервиса «Яндекс Метрика», в соответствии с Политикой по обработке персональных данных путем нажатия на кнопку «Ок»